| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENOV | Common stock, par value $.001 | -Sell | -$85,372 | -2,024 | -1.16% | $42.18 | 172,091 | Feb 25, 2022 | Direct | F1 |
| transaction | ENOV | Common stock, par value $.001 | +Grant/Award | $0 | +62,821 | +36.5% | $0.00 | 234,912 | Feb 25, 2022 | Direct | F2 |
| transaction | ENOV | Common stock, par value $.001 | -Sell | -$1,287,895 | -31,274 | -13.31% | $41.18 | 203,638 | Feb 28, 2022 | Direct | F1 |
| holding | ENOV | Common stock, par value $.001 | 2,312 | Feb 25, 2022 | By 401K Plan | ||||||
| holding | ENOV | Common stock, par value $.001 | 1,000 | Feb 25, 2022 | By trust for daughter | ||||||
| holding | ENOV | Common stock, par value $.001 | 1,000 | Feb 25, 2022 | By trust for daughter | ||||||
| holding | ENOV | Common stock, par value $.001 | 1,000 | Feb 25, 2022 | By trust for son |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). |
| F2 | Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021. |